Skip to content

Psychological and Lifestyle Factors on Health Outcomes

The Influence of Psychosocial and Lifestyle Factors on Immune Health and Injury Incidence During Phase One Training in UK Army Recruits

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04780867
Enrollment
1188
Registered
2021-03-04
Start date
2020-10-19
Completion date
2023-01-31
Last updated
2023-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Health, Injury, Psychological, Respiratory Tract Infections, Stress, Vaccination

Brief summary

Psychosocial and lifestyle factors in Army recruits likely contribute to increased susceptibility to infection and injury during basic Army training. The primary aim of this study is to assess the influence of psychosocial and lifestyle factors at the start of basic Army training on immune health (e.g. respiratory infection and antibody response to influenza vaccination) and injury during training, in an observational design. A secondary aim is to establish whether changes in psychosocial and lifestyle factors during training impact immune health (e.g. response to hepatitis B vaccination). Using an interventional design, participants will be randomly allocated into two experimental groups: (i) Routine vaccination group: to receive first hepatitis B vaccination at initial medical assessment upon entry to basic training and second hepatitis B vaccination 1 month later; (ii) Delayed vaccination group: to receive first hepatitis B vaccination during week 5 of training and second hepatitis B vaccination 1 month later.

Interventions

BEHAVIORALDelayed vaccination

First and second hepatitis B vaccinations will be delayed by 1 month in the interventional group to establish whether changes in psychosocial and lifestyle factors during training impact immune health.

Sponsors

University of Nottingham
CollaboratorOTHER
University of California, Los Angeles
CollaboratorOTHER
Loughborough University
CollaboratorOTHER
Ministry of Defence, United Kingdom
CollaboratorOTHER_GOV
Liverpool John Moores University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

For aim 1, an observational design will be used to examine the influence of psychosocial and lifestyle factors at the start of basic Army training on immune health (e.g. respiratory infection and antibody response to influenza vaccination) and injury during training. For aim 2, the recruited cohort will be divided into two groups: (i) Routine vaccination group: to receive first hepatitis B vaccination at initial medical assessment upon entry to basic training and second hepatitis B vaccination 1 month later; (ii) Delayed vaccination group: to receive first hepatitis B vaccination during week 5 of training and second hepatitis B vaccination 1 month later.

Eligibility

Sex/Gender
ALL
Age
16 Years to 33 Years
Healthy volunteers
Yes

Inclusion criteria

Men and women aged 16-33 years enrolled in phase one British Army training

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Antibody response to influenza vaccination - Aim 11 month
Physician diagnosed respiratory infection incidence - Aim 16 months
Physician diagnosed injury incidence - Aim 16 months
Antibody response to second hepatitis B vaccination - Aim 2Routine group: 3 months; Delay group: 4 months

Secondary

MeasureTime frame
Epstein Barr Virus serostatus/antibody titreBaseline and 1 month
Cytomegalovirus serostatus/antibody titreBaseline and 1 month
Antibody response to influenza vaccination4 months
Interleukin-6Baseline and 1 month
Hair cortisolBaseline
Torque Teno Virus plasma DNABaseline and 1 month
Antibody response to first hepatitis B vaccinationRoutine group: 1 months; Delay group: 2 months
C-reactive proteinBaseline, 1-day post vaccination and 1 month
Gene expression profilingBaseline and 1 month

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026